References
- Heslop HE, Congfen L, Krance RA. Epstein-Barr infection after bone marrow transplantation. Blood 1994;83:1706–1710.
- Kuehnle I, Huls MH, Liu Z, . CD20 monoclonal antibody (rituximab) for therapy of Epstein-Barr virus lymphoma after hemopoietic stem-cell transplantation. Blood 2000;95:1502–1505.
- Milpied N, Vasseur B, Parquet N, . Humanized anti-CD20 monoclonal antibody (rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients. Ann Oncol 2000;11(Suppl. 1):S113–S116.
- Polilli E, Sozio F, Mazzotta E, . Rapidly progressive and fatal EBV-related encephalitis in a patient with advanced HIV-1 infection at presentation: a case report and review of literature. New Microbiol 2010;33:275–280.
- Kittan NA, Beier F, Kurk K, . Isolated cerebral manifestation of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: a case of clinical and diagnostic challenges. Transpl Infect Dis 2011;13:524–530.
- van de Glind G, de Graaf S, Klein C, . Intrathecal rituximab treatment for pediatric post-transplant lymphoproliferative disorder of the central nervous system. Pediatr Blood Cancer 2008;50: 886–888.
- Bonney DK, Htwe EE, Turner A, . Sustained response to intrathecal rituximab in EBV associated post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant. Pediatr Blood Cancer 2012;58:459–461.
- Shah GD, Yahalom J, Correa DD, . Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 2007;25: 4730–4735.
- Batchelor TT, Lesser GJ, Grossman SA. Rituximab monotherapy for relapsed or refractory primary central nervous system lymphoma. J Clin Oncol 2008;26:(Suppl.): Abstract 2043.
- Ferreri AJ. How I treat primary CNS lymphoma. Blood 2011;118:510–522.
- Harjunpaa A, Wiklund T, Collan J, . Complement activation in circulation and central nervous system after rituximab (anti-CD20) treatment of B-cell lymphoma. Leuk Lymphoma 2001;42:731–738.
- Hänel M, Fiedler F, Thorns C. Anti-CD20 monoclonal antibody (rituximab) and cidofovir as successful treatment of an EBV-associated lymphoma with CNS involvement. Onkologie 2001;24:491–494.
- Nozzoli C, Bartolozzi B, Guidi S, . Epstein-Barr virus-associated post-transplant lymphoproliferative disease with central nervous system involvement after unrelated allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma 2006;47:167–169.
- Kordelas L, Trenschel R, Koldehoff M, . Successful treatment of EBV PTLD with CNS lymphomas with the monoclonal anti-CD20 antibody rituximab. Onkologie 2008;31:691–693.
- Pakakasama S, Eames GM, Morriss MC, . Treatment of Epstein-Barr virus lymphoproliferative disease after hematopoietic stem-cell transplantation with hydroxyurea and cytotoxic T-cell lymphocytes. Transplantation 2004;78:755–757.